 |
|
|
| |
Evaluation of sofosbuvir and simeprevir-based regimens
in the TRIO network - Academic and community treatment of a real-world, heterogeneous population
|
| |
| |
Reported by Jules Levin
AASLD Nov 8-11 Boston 2014
Douglas Dieterich1, Bruce Bacon2, Steven Flamm3, Kris Kowdley4, Scott Milligan5, Naoky Tsai6, Zobair Younossi7 and Eric Lawitz8
1Mount Sinai School of Medicine, 2Saint Louis University School of Medicine, 3Northwestern University Feinberg School of Medicine, 4Swedish Liver Center and Transplant Program, Swedish Medical Center, 5Trio Health Analytics, 6Queens Medical Center, University of Hawaii, 7Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 8The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX
|
| |
|
|
|
|
|
